GLOBAL BLOOD THERAPEUTICS IN's ticker is GBT and the CUSIP is 37890U108. A total of 68 filers reported holding GLOBAL BLOOD THERAPEUTICS IN in Q4 2015. The put-call ratio across all filers is - and the average weighting 0.5%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2020 | $221,000 | -92.6% | 5,000 | -93.2% | 0.00% | -100.0% |
| Q4 2018 | $3,005,000 | +247.8% | 73,200 | +222.1% | 0.01% | +300.0% |
| Q3 2018 | $864,000 | -15.9% | 22,728 | -0.0% | 0.00% | -25.0% |
| Q2 2018 | $1,027,000 | -10.1% | 22,729 | -45.6% | 0.00% | -33.3% |
| Q2 2017 | $1,143,000 | +2497.7% | 41,801 | +3380.5% | 0.01% | – |
| Q1 2017 | $44,000 | +1000.0% | 1,201 | +299.0% | 0.00% | – |
| Q4 2016 | $4,000 | -86.7% | 301 | -76.9% | 0.00% | – |
| Q3 2016 | $30,000 | +36.4% | 1,301 | 0.0% | 0.00% | – |
| Q2 2016 | $22,000 | +4.8% | 1,301 | 0.0% | 0.00% | – |
| Q1 2016 | $21,000 | -50.0% | 1,301 | 0.0% | 0.00% | – |
| Q4 2015 | $42,000 | – | 1,301 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Alerce Investment Management, L.P. | 356,270 | $24,262,000 | 23.36% |
| Twin Securities, Inc. | 376,669 | $25,651,000 | 11.94% |
| Paradigm Biocapital Advisors LP | 1,175,879 | $80,077,000 | 10.68% |
| Chicago Capital Management, LLC | 246,246 | $16,769,000 | 9.12% |
| HARVEST MANAGEMENT LLC | 141,500 | $9,636,000 | 7.78% |
| Fernwood Investment Management, LLC | 174,724 | $11,899,000 | 5.02% |
| ArchPoint Investors | 168,725 | $11,490,000 | 4.69% |
| HAVENS ADVISORS LLC | 46,000 | $3,133,000 | 4.69% |
| Perceptive Advisors | 2,322,247 | $158,145,000 | 4.59% |
| Crabel Capital Management, LLC | 112,680 | $7,674,000 | 4.48% |